NASDAQ:MTBC - Medical Transcription Billing Stock Price, Forecast & News

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

Medical Transcription Billing Corp (NASDAQ:MTBC) announced its earnings results on Wednesday, November, 6th. The technology company reported ($0.14) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.14). The technology company had revenue of $16.85 million for the quarter, compared to the consensus estimate of $16.06 million. Medical Transcription Billing had a negative net margin of 5.01% and a negative return on equity of 8.85%. View Medical Transcription Billing's Earnings History.

Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Friday, February 28th 2020. View Earnings Estimates for Medical Transcription Billing.

Medical Transcription Billing will be holding an earnings conference call on Friday, February 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Medical Transcription Billing updated its FY 2020 IntraDay earnings guidance on Friday, February, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100 million, compared to the consensus revenue estimate of $100.4 million.

4 equities research analysts have issued 12 month price objectives for Medical Transcription Billing's stock. Their forecasts range from $6.00 to $6.25. On average, they anticipate Medical Transcription Billing's stock price to reach $6.08 in the next twelve months. This suggests that the stock has a possible downside of 9.7%. View Analyst Price Targets for Medical Transcription Billing.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.

Media coverage about MTBC stock has trended somewhat negative on Sunday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Transcription Billing earned a media sentiment score of -1.8 on InfoTrie's scale. They also assigned media coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Medical Transcription Billing.

Medical Transcription Billing saw a increase in short interest in January. As of January 15th, there was short interest totalling 65,200 shares, an increase of 35.0% from the December 31st total of 48,300 shares. Based on an average daily trading volume, of 49,400 shares, the days-to-cover ratio is currently 1.3 days. Approximately 1.0% of the company's stock are short sold. View Medical Transcription Billing's Current Options Chain.

Some companies that are related to Medical Transcription Billing include eGain (EGAN), MiX Telematics (MIXT), Xunlei (XNET), Red Violet (RDVT), ChannelAdvisor (ECOM), DIRTT Environmental (DRTT), Iclick Interactive Asia Group (ICLK), Smith Micro Software (SMSI), SharpSpring (SHSP), MAM Software Group (MAMS), Inspired Entertainment (INSE), Great Elm Capital Group (GEC), Aware (AWRE), Cyren (CYRN) and Where Food Comes From (WFCF).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), Verastem (VSTM), NVIDIA (NVDA), Micron Technology (MU), Sophiris Bio (SPHS), AbbVie (ABBV), Alibaba Group (BABA), Advanced Micro Devices (AMD), Microbot Medical (MBOT) and Etsy (ETSY).

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MTBC stock can currently be purchased for approximately $6.74.

Medical Transcription Billing has a market capitalization of $82.36 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing.

The official website for Medical Transcription Billing is http://www.mtbc.com/.

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.